|
1
|
Li D, Xie K, Wolff R and Abbruzzese JL:
Pancreatic cancer. Lancet. 363:1049–1057. 2004. View Article : Google Scholar
|
|
2
|
Saif MW: Adjuvant therapy of pancreatic
cancer: beyond gemcitabine. In: Highlights from the ‘2011 ASCO
Gastrointestinal Cancers Symposium’; San Francisco, CA, USA.
January 20–22, 2011; JOP. 12. pp. 106–109. 2011, PubMed/NCBI
|
|
3
|
Theissen G, Pardon B and Wagner R: A
quantitative assessment for transcriptional pausing of
DNA-dependent RNA polymerases in vitro. Anal Biochem. 189:254–261.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Block G, Patterson B and Subar A: Fruit,
vegetables, and cancer prevention: a review of the epidemiological
evidence. Nutr Cancer. 18:1–29. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bueno de Mesquita HB, Maisonneuve P,
Moerman CJ, Runia S and Boyle P: Life-time history of smoking and
exocrine carcinoma of the pancreas: a population-based case-control
study in The Netherlands. Int J Cancer. 49:816–822. 1991.
|
|
6
|
Cassileth BR: Alternative and
complementary medicine. Separating the wheat from the chaff.
Cancer. 86:1900–1902. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bae K: The Medicinal Plants of Korea.
Kyu-Hak Press; Seoul: pp. 1391999
|
|
8
|
Ye WC, Ou BX, Ji NN, Zhao SX, Ye T,
McKervey MA and Stevenson P: Patensin, a saponin from Pulsatilla
patens varmultifida. Phytochemistry. 39:937–939. 1995.
View Article : Google Scholar
|
|
9
|
Ye WC, Ji NN, Zhao SX, Liu JH, Ye T,
McKervey MA and Stevenson P: Triterpenoids from Pulsatilla
chinensis. Phytochemistry. 42:799–802. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bang SC, Lee JH, Song GY, Kim DH, Yoon MY
and Ahn BZ: Antitumor activity of Pulsatilla koreana
saponins and their structure-activity relationship. Chem Pharm
Bull. 53:1451–1454. 2005.PubMed/NCBI
|
|
11
|
Kim Y, Bang SC, Lee JH and Ahn BZ:
Pulsatilla saponin D: the antitumor principle from
Pulsatilla koreana. Arch Pharm Res. 27:915–918. 2004.
View Article : Google Scholar
|
|
12
|
Dontu G, Abdallah WM, Foley JM, Jackson
KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and
transcriptional profiling of human mammary stem/progenitor cells.
Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Smith M and Boon HS: Counseling cancer
patients about herbal medicine. Patient Educ Couns. 38:109–120.
1999. View Article : Google Scholar
|
|
14
|
Li Y, Ahmed F, Ali S, Philip PA, Kucuk O
and Sarkar FH: Inactivation of nuclear factor κB by soy isoflavone
genistein contributes to increased apoptosis induced by
chemotherapeutic agents in human cancer cells. Cancer Res.
65:6934–6942. 2005.
|
|
15
|
Li F, Fernandez PP, Rajendran P, Hui KM
and Sethi G: Diosgenin, a steroidal saponin, inhibits STAT3
signaling pathway leading to suppression of proliferation and
chemosensitization of human hepatocellular carcinoma cells. Cancer
Lett. 292:197–207. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng L, Zhou Y, Kong de Y and Zhang WD:
Antitumor activities of dammarane triterpene saponins from
Bacopa monniera. Phytother Res. 24:864–868. 2010.PubMed/NCBI
|
|
17
|
Tin MM, Cho CH, Chan K, James AE and Ko
JK: Astragalus saponins induce growth inhibition and
apoptosis in human colon cancer cells and tumor xenograft.
Carcinogenesis. 28:1347–1355. 2007. View Article : Google Scholar
|
|
18
|
Chen PS, Shih YW, Huang HC and Cheng HW:
Diosgenin, a steroidal saponin, inhibits migration and invasion of
human prostate cancer PC-3 cells by reducing matrix
metalloproteinases expression. PLoS One. 6:e201642011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Petronilli V, Penzo D, Scorrano L,
Bernardi P and Di Lisa F: The mitochondrial permeability
transition, release of cytochrome c and cell death.
Correlation with the duration of pore openings in situ. J
Biol Chem. 276:12030–12034. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Armstrong JS: Mitochondria: a target for
cancer therapy. Br J Pharmacol. 147:239–248. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Folkman J: Angiogenesis. Annu Rev Med.
57:1–18. 2006. View Article : Google Scholar
|
|
22
|
Xia C, Meng Q, Cao Z, Shi X and Jiang BH:
Regulation of angiogenesis and tumor growth by p110 alpha and AKT1
via VEGF expression. J Cell Physiol. 209:56–66. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jiang BH, Rue E, Wang GL, Roe R and
Semenza GL: Dimerization, DNA binding, and transactivation
properties of hypoxia-inducible factor 1. J Biol Chem.
271:17771–17778. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hong SW, Jung KH, Lee HS, Choi MJ, Son MK,
Zheng HM and Hong SS: SB365 inhibits angiogenesis and induces
apoptosis of hepatocellular carcinoma through modulation of
PI3K/Akt/mTOR signaling pathway. Cancer Sci. 103:1929–1937. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Indraccolo S, Stievano L, Minuzzo S,
Tosello V, Esposito G, Piovan E, Zamarchi R, Chieco-Bianchi L and
Amadori A: Interruption of tumor dormancy by a transient angiogenic
burst within the tumor microenvironment. Proc Natl Acad Sci USA.
103:4216–4221. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hoeben A, Landuyt B, Highley MS, Wildiers
H, Van Oosterom AT and De Bruijn EA: Vascular endothelial growth
factor and angiogenesis. Pharmacol Rev. 56:549–580. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Alitalo A and Detmar M: Interaction of
tumor cells and lymphatic vessels in cancer progression. Oncogene.
31:4499–4508. 2012. View Article : Google Scholar : PubMed/NCBI
|
